We are live on
!
Find out more
VI
Vestcor Inc Portfolio holdings
AUM
$3.63B
1-Year Est. Return
21.49%
This Fund
S&P 500
This Quarter
Est. Return
+1.29%
1 Year Est. Return
+21.49%
3 Year Est. Return
+77.59%
5 Year Est. Return
+109.03%
10 Year Est. Return
–
AUM
$3.63B
AUM Growth
+$123M
(+3.5%)
Cap. Flow
+$186M
Cap. Flow
% of AUM
5.11%
Top 10 Holdings %
Top 10 Hldgs %
18.05%
Holding
1,319
New
163
Increased
386
Reduced
255
Closed
127
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$52.5M |
| 2 |
Duke Energy
DUK
|
+$11.9M |
| 3 |
Cognizant
CTSH
|
+$10.8M |
| 4 |
Realty Income
O
|
+$9.5M |
| 5 |
Cencora
COR
|
+$8.86M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$18.5M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$17.2M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$14.4M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$14.2M |
| 5 |
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
|
+$9.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 10.61% |
| 3 | Financials | 9.99% |
| 4 | Real Estate | 9.52% |
| 5 | Communication Services | 9.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Nelnet
NNI
$4.79B
| $127K | ﹤0.01% |
987
-53
| -5% | -$6.96K |
|
1102
AdaptHealth
AHCO
$1.46B
| $126K | ﹤0.01% |
10,624
| – | – |
|
1103
Paycom
PAYC
$6.78B
| $126K | ﹤0.01% |
1,039
-394
| -27% | -$52.7K |
|
1104
Skywest
SKYW
$4.11B
| $126K | ﹤0.01% |
1,373
| – | – |
|
1105
VF Corp
VFC
$6.68B
| $126K | ﹤0.01% |
+7,395
| New | +$139K |
|
1106
American Eagle Outfitters
AEO
$2.85B
| $124K | ﹤0.01% |
+7,407
| New | +$166K |
|
1107
Enphase Energy
ENPH
$4.84B
| $124K | ﹤0.01% |
+3,267
| New | +$136K |
|
1108
Futu Holdings
FUTU
$13.9B
| $124K | ﹤0.01% |
907
| – | – |
|
|
SAFE
1109
Safehold
SAFE
$1.19B
| $124K | ﹤0.01% |
+9,182
| New | +$136K |
|
1110
Century Aluminum
CENX
$4.57B
| $121K | ﹤0.01% |
+2,062
| New | +$103K |
|
1111
Macy's
M
$6.15B
| $120K | ﹤0.01% |
6,609
| – | – |
|
1112
United Fire Group
UFCS
$1.32B
| $119K | ﹤0.01% |
3,203
| – | – |
|
1113
Interparfums
IPAR
$3.92B
| $117K | ﹤0.01% |
1,288
| – | – |
|
1114
Skyward Specialty Insurance
SKWD
$2.45B
| $116K | ﹤0.01% |
+2,656
| New | +$121K |
|
1115
CONMED
CNMD
$1.29B
| $114K | ﹤0.01% |
3,216
-2,908
| -47% | -$118K |
|
1116
Piper Sandler
PIPR
$5.14B
| $114K | ﹤0.01% |
+1,487
| New | +$122K |
|
1117
Moelis & Co
MC
$4.98B
| $110K | ﹤0.01% |
1,937
| – | – |
|
|
GOOD
1118
Gladstone Commercial Corp
GOOD
$627M
| $109K | ﹤0.01% |
+9,529
| New | +$112K |
|
|
AIV
1119
Aimco
AIV
$380M
| $108K | ﹤0.01% |
+26,623
| New | +$139K |
|
|
NAGE
1120
Niagen Bioscience
NAGE
$256M
| $108K | ﹤0.01% |
24,457
| – | – |
|
|
ALX
1121
Alexander's
ALX
$1.4B
| $107K | ﹤0.01% |
+453
| New | +$108K |
|
|
NXRT
1122
NexPoint Residential Trust
NXRT
$665M
| $106K | ﹤0.01% |
+4,244
| New | +$122K |
|
1123
Blue Owl Capital
OWL
$6.39B
| $105K | ﹤0.01% |
+11,499
| New | +$139K |
|
1124
Hamilton Lane
HLNE
$3.63B
| $104K | ﹤0.01% |
1,043
| – | – |
|
|
SEZL
1125
Sezzle
SEZL
$5.17B
| $104K | ﹤0.01% |
1,644
+1,283
| +355% | +$87.4K |
|
Similar funds
JFG
GCM
ACM
APP
SCM
OCM
WB
SL
Vestcor Inc's Q1 2026 Portfolio in Review
As of Q1 2026, Vestcor Inc held 1,319 positions worth $3.63B, up 3.5% from $3.51B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Vestcor Inc deployed $186M of net new capital in Q1 2026, opening 163 new positions and adding to 386 existing holdings. Its largest new stake was Revolution Medicines: 63,077 shares worth $6.13M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $18.5M trimmed.
- Vestcor Inc's largest Q1 2026 buy was Revolution Medicines: 63,077 shares worth $6.13M.
- Vestcor Inc added most to iShares Core MSCI Emerging Markets ETF in Q1 2026, an estimated $52.5M increase.
- Vestcor Inc's biggest Q1 2026 reduction was Bristol-Myers Squibb, cutting an estimated $18.5M.
- Vestcor Inc fully exited Avidity Biosciences in Q1 2026, selling an estimated $14.4M.
- Vestcor Inc's ten largest holdings make up 18% of its $3.63B portfolio in Q1 2026.
- Vestcor Inc opened 163 new positions and closed 127 in Q1 2026.
- Vestcor Inc's portfolio value rose 3.5% quarter-over-quarter to $3.63B.
Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.